Quarterly Reports :: Ligand Pharmaceuticals Incorporated (LGND)

Date	Form	Description	Docs	XBRL	Pages
11/08/07	10-Q	Quarterly report pursuant to Section 13 or 15(d) Related Documents EX-31.1 EX-31.2 EX-32.1 EX-32.2			81
08/08/07	10-Q	Quarterly report pursuant to Section 13 or 15(d) Related Documents EX-10.314 EX-10.316 EX-10.317 EX-31.1 EX-31.2 EX-32.1 EX-32.2			86
05/23/07	10-Q/A	Quarterly report pursuant to Section 13 or 15(d) Related Documents EX-31.1 EX-31.2 EX-32.1 EX-32.2			69
05/10/07	10-Q	Quarterly report pursuant to Section 13 or 15(d) Related Documents EX-31.1 EX-31.2 EX-32.1 EX-32.2			69
11/14/06	10-Q	Quarterly report pursuant to Section 13 or 15(d) Related Documents EX-10.298 EX-31.1 EX-31.2 EX-32.1 EX-32.2			80
11/09/06	NT 10-Q	Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB			3
08/09/06	10-Q	Quarterly report pursuant to Section 13 or 15(d) Related Documents EX-10.293 EX-31.1 EX-31.2 EX-32.1 EX-32.2			73
05/15/06	10-Q	Quarterly report pursuant to Section 13 or 15(d) Related Documents EX-10.267 EX-31.1 EX-31.2 EX-32.1 EX-32.2			91
05/10/06	NT 10-Q	Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB			3
12/09/05	10-Q	Quarterly report pursuant to Section 13 or 15(d) Related Documents EX-10.286 EX-31.1 EX-31.2 EX-32.1 EX-32.2			83